Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 43 Squamous Cell Carcinoma of Head and Neck 12 Rectal Neoplasms 12 Colonic Neoplasms 12 Neoplasm Metastasis 9 Head and Neck Neoplasms 8 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Colorectal Cancer Metastatic 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Carcinoma, Squamous Cell 2 mCRC 1 Stomach Neoplasms 1 Skin Neoplasms 1 Recurrence 1 Neoplasms, Unknown Primary 1 Nasopharyngeal Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Metastasis Colon Cancer 1 Incurable Colorectal Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1

Interventions

apatinib 2 gallium 68 PSMA-11 1 Radiotherapy, Intensity-Modulated 1 Protons 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Imatinib Mesylate 1 Cetuximab 1 68Ga-FAPI 1 177Lu-EB-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Adenoid Cystic × Cetuximab × Clear all

NCT01192087 2013-04-24

ACCEPT

Heidelberg University

Phase 1/2 Unknown

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡